Advertisements

Inflamyl Fort

Quick links to important sections

Inflamyl Fort

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Inflamyl Fort

Property Description
Active Ingredient Mefenamic Acid
Form Oral Solid (Tablets or Capsules)
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common Use Symptomatic relief of pain, inflammation, and fever
Origin Synthetic Anthranilic Acid Derivative

What Type of Medicine is Inflamyl Fort?

Inflamyl Fort is a prescription-only (Rx) Nonsteroidal Anti-inflammatory Drug (NSAID), a synthetic, single-ingredient product designated for oral administration. The medication is chemically a member of the fenamate group, distinguishing it within the broader NSAID class. Its active substance is Mefenamic Acid, which is derived from the anthranilic acid chemical structure. The "Fort" designation often signifies a higher strength formulation, positioning it for more intense or acute symptomatic management compared to standard versions of Mefenamic Acid.


Mefenamic Acid: Composition and Therapeutic Purpose

The entire therapeutic effectiveness of Inflamyl Fort is delivered by its active ingredient, Mefenamic Acid, which is formulated alongside solid pharmaceutical excipients to constitute the final oral dosage form. Mefenamic Acid functions as a potent Cyclooxygenase (COX) inhibitor, a mechanism that inhibits inflammatory mediators. The therapeutic purpose is therefore the symptomatic management of painful affections and elevated body temperatures associated with various conditions. This action provides three core benefits simultaneously: analgesic (pain-relieving), anti-inflammatory (swelling reduction), and antipyretic (fever reduction), supporting overall symptomatic relief in states of acute inflammation or fever.

Regulatory References

  1. NIH LiverTox Mefenamic Acid Monograph
Advertisements

What side effects are possible with Inflamyl Fort?

Possible side effects and safety information

As a Nonsteroidal Anti-inflammatory Drug (NSAID), Mefenamic Acid (the active ingredient in Inflamyl Fort) carries officially documented risks concerning both the Gastrointestinal and Cardiovascular systems. The safety profile, defined by regulatory agencies, mandates explicit statements regarding serious, potentially fatal thrombotic events, such as myocardial infarction (MI) and stroke, which may increase in risk with the duration of use. Similarly, the possibility of serious gastrointestinal events, including bleeding, ulceration, and perforation, is documented as a primary safety concern.


Adverse Reaction Classification

Adverse effects are classified by the affected organ system, with the Gastrointestinal System being the most commonly associated site for non-serious reactions. Diarrhea is frequently noted as a common side effect, often subsiding with a dosage adjustment. Other commonly listed effects include nausea, vomiting, headache, and dizziness.

Serious, yet rare, adverse reactions affecting the Renal System (e.g., renal failure) and Dermatological System (e.g., Stevens-Johnson Syndrome) are also detailed in official labeling.


Population-Specific Safety Notes

The regulatory profile outlines specific constraints for certain patient groups. Older adults are at a higher risk for adverse reactions, especially serious gastrointestinal complications. The medication is contraindicated during the third trimester of pregnancy due to the risk of premature closure of the fetal ductus arteriosus. Furthermore, it is not to be used for pain following Coronary Artery Bypass Graft (CABG) surgery or in individuals with severe renal impairment.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Inflamyl Fort (Mefenamic Acid) requires immediate professional intervention, as no specific antidote is known according to regulatory documentation.

Documented Manifestations and Severe Outcomes

Overdose may initially present with common signs affecting the Gastrointestinal System, including nausea, vomiting, diarrhea, and epigastric pain. Central Nervous System (CNS) effects are also documented, encompassing headache, dizziness, lethargy, and mental confusion.

The most severe consequences are primarily related to CNS and systemic organ toxicity. Regulators note the potential for serious outcomes, including tonic-clonic convulsions (seizures), which are a particular risk with Mefenamic Acid overdose. Life-threatening complications also involve acute renal failure, severe gastrointestinal hemorrhage, and, in cases of massive ingestion, coma.

Emergency Actions and Treatment

Upon any suspicion of overdose, the official regulatory guidance is to seek immediate medical attention or contact a poison control center immediately. Emergency medical care is required due to the risk of severe complications.

The management approach, as documented, is symptomatic and supportive treatment. Procedures such as administering activated charcoal and measures like gastric emptying may be considered in recent large ingestions. Continuous hospital monitoring of vital signs and renal function is necessary to manage potential organ injury. Children are noted to have an increased susceptibility to severe CNS effects, particularly convulsions, in overdose scenarios.

Advertisements

Therapeutic Uses of Inflamyl Fort

What Inflamyl Fort Treats: Main Uses and Benefits

Inflamyl Fort is a prescription Nonsteroidal Anti-inflammatory Drug (NSAID) used for the short-term symptomatic management of physical discomfort and fever. It is generally indicated to help alleviate pain, inflammation, and fever in conditions characterized by episodic or fluctuating manifestations.

This medication is utilized for conditions presenting with acute episodes of mild to moderate pain, including headache, dental pain, and musculoskeletal discomfort. It is also used for easing symptoms in conditions such as Osteoarthritis, Rheumatoid Arthritis, primary dysmenorrhea (menstrual cramps), and menorrhagia (heavy menstrual bleeding).

It addresses symptoms related to physical discomfort, which may help individuals manage symptom fluctuations and provide support during episodes of heightened discomfort when symptoms interfere with routine activities.


Quick Fact: Relief for Menstrual Pain

Inflamyl Fort is used in situations involving certain distressing symptoms of the menstrual cycle, including pain (cramping) and excessive flow, providing support that helps ease the overall symptom burden during these episodes.

Advertisements

Eligibility and Restrictions for Use

Eligibility and Contraindications for Inflamyl Fort

Inflamyl Fort is an anti-inflammatory medicine with specific restrictions on patient eligibility, as defined in regulatory documentation. Use is only permitted for adults and is contraindicated for several populations due to safety concerns.

Populations That Must Not Use Inflamyl Fort

Category Contraindication Criteria
Age Children and adolescents under 18 years of age.
Hypersensitivity Known allergy or hypersensitivity to the active substance, excipients, or history of reactions (like asthma, rhinitis, urticaria) to acetylsalicylic acid or other NSAIDs.
Physiological State The third trimester of pregnancy.
Clinical History Active or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of bleeding or ulceration).
Severe Organ Impairment Severe heart failure, severe hepatic impairment, or severe renal impairment (creatinine clearance <30 ml/min).

Other Significant Restrictions

Category Restriction Status
Pregnancy Not recommended during the first and second trimesters unless clearly necessary and only on medical advice.
Lactation Not recommended for use while breast-feeding as the medicine is excreted in breast milk.
Other Conditions Use requires special consideration or is not recommended in patients with moderate to severe heart failure, moderate renal/hepatic impairment, current acute asthma, history of gastrointestinal bleeding, or coagulation disorders.

This information is based strictly on formal regulatory documentation regarding eligibility and prohibition of use and does not constitute medical advice, instructions for use, or a discussion of therapeutic benefits or side effects.

Advertisements

What should I know about interactions with other medicines?

Inflamyl Fort (Mefenamic Acid) interacts with various medicines and substances, primarily through two documented patterns: Pharmacodynamic Risk Amplification and Pharmacokinetic Drug Exposure Alteration. Regulatory guidance directs avoidance of concomitant use with other systemic NSAIDs due to the increased risk of serious gastrointestinal events.

Pharmacodynamic Interactions lead to an increased risk of bleeding and organ toxicity. Co-administration with Oral Anticoagulants (e.g., Warfarin), Anti-platelet Agents (including low-dose Aspirin), Corticosteroids, or SSRIs significantly increases the risk of GI bleeding or ulceration. Mefenamic Acid also reduces the effectiveness of certain blood pressure medications, including ACE Inhibitors and Diuretics. Combining it with drugs like Ciclosporin or Tacrolimus carries a possible increased risk of nephrotoxicity. Alcohol may also increase the risk of gastrointestinal bleeding.

Pharmacokinetic Interactions affect drug levels in the body. Mefenamic Acid may reduce the clearance of Lithium and Methotrexate, leading to elevated plasma concentrations and a risk of toxicity. Magnesium Hydroxide-containing antacids significantly increase Mefenamic Acid absorption. Mefenamic Acid also inhibits the metabolism of some Oral Hypoglycaemic Agents, prolonging their effect and raising the risk of hypoglycemia.

Specific Restrictions and Timing Rules mandate that Mefenamic Acid should not be taken for 8–12 days after Mifepristone administration. The medication is contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Advertisements

Mechanism of Action

Non-Selective Inhibition of Prostaglandin Synthesis

The core biological action of the drug, Mefenamic Acid, involves the non-selective inhibition of Cyclooxygenase (COX) enzymes (COX-1 and COX-2). By reversibly blocking the active sites of these enzymes, the drug rapidly suppresses the formation of prostaglandins, a class of lipid mediators derived from the Arachidonic Acid cascade . This mechanism modifies early molecular steps that shape systemic physiological outcomes by modifying the pathway activity of eicosanoid-mediated responses.


Modulation of Peripheral Pain Signaling and Central Thermoregulation

The resulting suppression of prostaglandins leads to a dual physiological effect. Peripherally, the reduction in these mediators decreases the heightened sensitivity (sensitization) of nociceptors (pain-sensing neurons) to other pain mediators. Centrally, the mechanism extends to the hypothalamus, where the inhibition of Prostaglandin E2 (mathrmPGE2) synthesis facilitates the re-adjustment of the elevated body temperature set-point, initiating the body’s natural heat-dissipation processes and influencing the central thermoregulatory mechanisms.

Advertisements

Dosage and Administration Information

How to Use Inflamyl Fort

Instructions for the correct use of Inflamyl Fort are established to ensure standardized administration.

Official Administration Guidelines

Administration Scope Official Instruction
Route of Administration Oral. Swallow the tablet whole.
Dosing Schedule One tablet, to be taken twice daily.
Timing in Relation to Meals Take preferably with or immediately after food.
Preparation Requirements None. Do not crush, break, or chew the tablet.
Age-Group Administration Indicated for adults and children above 12 years of age.
Missed-Dose Rules If a dose is missed, take it as soon as possible unless it is nearly time for the next dose. If so, skip the missed dose and resume the regular schedule. Do not take a double dose.
Special Procedural Conditions The lowest effective dose should be used for the shortest duration necessary to control symptoms.

Procedural Structure

The established protocol requires taking a single 500 mg tablet by mouth, swallowing it whole with liquid. This procedure is performed twice daily, resulting in a maximum daily dose of two tablets. It is a requirement that the medicine be taken with or after food to adhere to the use criteria. The overall regimen is restricted by the need to use the lowest dosage for the shortest time.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Inflamyl Fort

Evidence for Use in Acute Symptomatic Pain

The primary research base for Inflamyl Fort (Mefenamic Acid) is applied in studies examining patient-reported experiences related to discomfort. This evidence largely consists of a substantial body of research consisting of short-term Randomized Controlled Trials (RCTs) and supporting systematic reviews.

Researchers studied populations of adults (generally ge 14 years of age) who were experiencing mild to moderate acute pain. The main outcomes studied were related to outcomes linked to inflammatory or irritative states, specifically measuring changes in pain intensity and the rate of use of rescue pain medication in observed populations.

The findings describe patterns observed in the studies where outcomes related to outcomes capturing phases of heightened symptom activity were monitored over short durations. The available research is predominantly limited to short-term follow-up, typically lasting only a single dose or up to about 7 days of continuous use. There is limited information for long-term outcomes, and research applied in studies examining chronic pain patterns remains limited.


Evidence for Gynecological Uses: Primary Dysmenorrhea and Menorrhagia

Research into Inflamyl Fort was evaluated in studies relevant in trials assessing short-term or episodic symptom patterns related to the menstrual cycle: menstrual pain (Primary Dysmenorrhea) and heavy menstrual bleeding (Menorrhagia).

For primary dysmenorrhea, research was evaluated in studies conducted during periods of increased symptom activity. These studies explored how symptoms evolved in the observed populations, specifically examining changes in pain severity scores and outcomes reflecting daily functioning or activity level.

Research exploring heavy menstrual bleeding focused on objective measurement methods to assess blood loss volume. The evidence here is considered limited when compared to the existing research base for acute pain, with some reviews noting that certainty remains low or Moderate. Comparative evidence against other standard treatments for heavy bleeding is lacking or was observed in some studies to have mixed findings, and the evidence quality varies across studies where sample sizes were modest in some reports.


Areas of Uncertainty and Research Gaps

The main limitations include that the follow-up durations were limited across many key studies. Limited data are available for research specifically focusing on pediatric populations (specifically children under 14 years of age), a key area where data remain insufficient, as noted in regulatory summaries. Overall, the research structure indicates the existence of a substantial body of research for acute, short-term use, but provides limited insight into long-term outcomes or application in all potential patient groups.

Key Studies & References

  1. NIH LiverTox: Mefenamic Acid
  2. Nonsteroidal anti-inflammatory drugs in primary care: use, trends, and safety (Systematic Review)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Inflamyl Fort (FAQ)

Q: How long does it typically take to start feeling the effects of Inflamyl Fort?

A: Official product information, often found in the pharmacokinetics section of regulatory documents, describes the drug as being rapidly absorbed after oral administration. Evidence indicates that mean peak plasma levels, a measurement which is often used to describe how quickly the drug reaches its highest concentration in the bloodstream, are typically attained within two to four hours following a single oral dose.


Q: Can Inflamyl Fort be used for general body aches?

A: The regulatory documents establish that the medicine is indicated for the symptomatic relief of mild to moderate acute pain and related conditions. The drug’s official indications describe its intended use for the symptomatic relief of mild to moderate acute pain.


Q: Can Inflamyl Fort be taken with supplements like vitamins or herbs?

A: Regulatory guidance describes the importance of informing a healthcare professional about all products being used. This comprehensive guidance includes all prescription and over-the-counter medications, as well as any vitamins, dietary, or herbal supplements, due to the potential for interactions.


Q: Is Inflamyl Fort known to interact with birth control pills?

A: Specific warnings exist regarding the class of drugs to which Inflamyl Fort belongs. Some nonsteroidal anti-inflammatory drugs (NSAIDs) have been noted to potentially increase the risk of high potassium levels when used with certain oral contraceptives that contain the ingredient drospirenone. Official information indicates that caution and monitoring may be considered for high-risk patients who use this combination.


Q: What is the main difference between Inflamyl Fort and regular Inflamyl?

A: The 'Fort' designation, or Forte, often signals a higher strength formulation of the active ingredient, Mefenamic Acid, compared to a standard version. Official documentation will specify the exact strength (e.g., 500 mg) of the particular tablet or capsule being described.


Q: Is Inflamyl Fort considered a narcotic or opioid?

A: According to official classification systems from national regulatory bodies, Inflamyl Fort's active ingredient, Mefenamic Acid, is solely classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). It is not classified as a narcotic or opioid substance.


Q: What is the official purpose of the 'Fort' designation in the drug name?

A: In pharmaceutical naming conventions, the term 'Fort' is commonly applied to a product to indicate that it is a stronger concentration or a higher dose formulation. This stronger concentration is generally used to manage more intense or acute symptomatic needs compared to a lower-strength version of the same medicine.


Q: Why do official sources list so many potential drug interactions for Inflamyl Fort?

A: Official sources provide comprehensive interaction warnings because the drug's mechanism can lead to two major documented patterns. One is Pharmacodynamic Risk Amplification, which increases the risk of side effects like bleeding, and the other is Pharmacokinetic Drug Exposure Alteration, which means the drug can affect how the body processes other medicines, potentially altering their effectiveness or safety.


Q: What are the official restrictions on driving while using Inflamyl Fort?

A: Patient guidance sections in official documents typically advise exercising caution regarding activities that demand full mental alertness, such as driving or operating heavy machinery. This caution is advised because common side effects of the medication can include effects on the central nervous system, such as headache and dizziness.


Q: How long does Inflamyl Fort stay in your system?

A: Official information regarding the drug's profile indicates that Mefenamic Acid has an elimination half-life of approximately two hours. This measurement is used to describe the rate at which the concentration of the medicine decreases in the bloodstream.


Q: What is the role of Inflamyl Fort in managing chronic joint discomfort?

A: Regulatory reviews of the research base note that the evidence for the use of this drug in chronic pain patterns or long-term outcomes remains limited. Most available studies have focused primarily on the drug’s application for acute symptomatic relief over short treatment periods.


Q: Is Inflamyl Fort habit-forming or addictive?

A: Inflamyl Fort is a Nonsteroidal Anti-inflammatory Drug (NSAID) and is not classified as a controlled substance by regulatory agencies. This classification indicates that the drug is not associated with the development of physical dependence or risks of addiction or habit formation.


Q: Does Inflamyl Fort contain any steroids?

A: The active ingredient in Inflamyl Fort, Mefenamic Acid, belongs to the Nonsteroidal Anti-inflammatory Drug (NSAID) class. This classification confirms that the medication is not a steroid and does not contain corticosteroids.


Q: Is there a maximum time recommended for continuous use of Inflamyl Fort?

A: Official regulatory guidelines for Mefenamic Acid specify limits for continuous treatment duration. For the management of acute pain, treatment should generally not exceed seven days. Use for menstrual cramps is typically restricted to two to three days per menstrual cycle.


Q: Can I use Inflamyl Fort before or after minor surgery?

A: The medication is strictly contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery. Due to the potential risk of bleeding associated with its drug class, official guidance often raises caution regarding the use of nonsteroidal anti-inflammatory drugs before most surgical procedures.


Q: Is there a specific time of day Inflamyl Fort is recommended to be taken?

A: Official administration instructions define the dosage frequency as 'twice daily' and mandate taking the medicine 'with or immediately after food.' Regulatory documents do not typically specify a mandatory time of day, such as morning versus evening, beyond these required scheduling and meal conditions.


Q: Are there any specific laboratory tests required before starting Inflamyl Fort?

A: Regulatory guidance suggests that patients receiving prolonged therapy may be subject to regular surveillance. Official monitoring guidance for long-term use includes checking for potential signs of adverse events such as liver dysfunction, which may necessitate laboratory testing.


Q: What are the restrictions on donating blood while taking Inflamyl Fort?

A: Mefenamic Acid is a type of anti-inflammatory drug that can affect platelet function. For this reason, official blood donation guidance frequently states that while a person may be eligible to donate whole blood, the blood components, specifically platelets, may be considered unsuitable for transfusion.


Q: Are there specific food types I should avoid while using Inflamyl Fort?

A: Official regulatory documentation explicitly includes a warning regarding the consumption of alcohol while using the drug. This is because using alcohol can increase the serious risk of gastrointestinal bleeding and ulceration associated with the medication.


Q: Does Inflamyl Fort have a risk of withdrawal symptoms?

A: Official drug classification confirms that Mefenamic Acid is a Nonsteroidal Anti-inflammatory Drug (NSAID) and not a controlled substance. Therefore, the medication is not associated with the development of physical dependence or the occurrence of withdrawal symptoms when discontinued.

Advertisements

How should Inflamyl Fort be stored and disposed of?

How to Store and Dispose of Inflamyl Fort?

The storage and disposal of Inflamyl Fort (Mefenamic Acid) are strictly governed by regulatory requirements to ensure the product remains chemically stable and to prevent accidental ingestion or environmental contamination.

Storage & Disposal Scope Official Regulatory Requirement
Storage Temperature Must be stored at Controlled Room Temperature (20 C to 25 C or 68 F to 77 F), with excursions permitted to 30 C (86 F).
Handling/Packaging Keep the medication in a tightly closed container to protect it from moisture and maintain its integrity.
Child Protection Keep out of the reach of children (a mandatory safety requirement for all prescription medication).
Disposal Instructions Do not flush the product down the toilet or pour it down the sink. Dispose of unused or expired medicine through a drug take-back program. If unavailable, mix the product with an undesirable substance (e.g., dirt or coffee grounds) and place the mixture in a sealed plastic bag before discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Inflamyl Fort found in:

A-Z Index: